Towfighi Amytis, Cheng Eric M, Ayala-Rivera Monica, Barry Frances, McCreath Heather, Ganz David A, Lee Martin L, Sanossian Nerses, Mehta Bijal, Dutta Tara, Razmara Ali, Bryg Robert, Song Shlee S, Willis Phyllis, Wu Shinyi, Ramirez Magaly, Richards Adam, Jackson Nicholas, Wacksman Jeremy, Mittman Brian, Tran Jamie, Johnson Renee R, Ediss Chris, Sivers-Teixeira Theresa, Shaby Betty, Montoya Ana L, Corrales Marilyn, Mojarro-Huang Elizabeth, Castro Marissa, Gomez Patricia, Muñoz Cynthia, Garcia Diamond, Moreno Lilian, Fernandez Maura, Lopez Enrique, Valdez Sarah, Haber Hilary R, Hill Valerie A, Rao Neal M, Martinez Beatrice, Hudson Lillie, Valle Natalie P, Vickrey Barbara G
University of Southern California, Los Angeles.
Los Angeles County Department of Health Services, Los Angeles, California.
JAMA Netw Open. 2021 Feb 1;4(2):e2036227. doi: 10.1001/jamanetworkopen.2020.36227.
Few stroke survivors meet recommended cardiovascular goals, particularly among racial/ethnic minority populations, such as Black or Hispanic individuals, or socioeconomically disadvantaged populations.
To determine if a chronic care model-based, community health worker (CHW), advanced practice clinician (APC; including nurse practitioners or physician assistants), and physician team intervention improves risk factor control after stroke in a safety-net setting (ie, health care setting where all individuals receive care, regardless of health insurance status or ability to pay).
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial included participants recruited from 5 hospitals serving low-income populations in Los Angeles County, California, as part of the Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities (SUCCEED) clinical trial. Inclusion criteria were age 40 years or older; experience of ischemic or hemorrhagic stroke or transient ischemic attack (TIA) no more than 90 days prior; systolic blood pressure (BP) of 130 mm Hg or greater or 120 to 130 mm Hg with history of hypertension or using hypertensive medications; and English or Spanish language proficiency. The exclusion criterion was inability to consent. Among 887 individuals screened for eligibility, 542 individuals were eligible, and 487 individuals were enrolled and randomized, stratified by stroke type (ischemic or TIA vs hemorrhagic), language (English vs Spanish), and site to usual care vs intervention in a 1:1 fashion. The study was conducted from February 2014 to September 2018, and data were analyzed from October 2018 to November 2020.
Participants randomized to intervention were offered a multimodal coordinated care intervention, including hypothesized core components (ie, ≥3 APC clinic visits, ≥3 CHW home visits, and Chronic Disease Self-Management Program workshops), and additional telephone visits, protocol-driven risk factor management, culturally and linguistically tailored education materials, and self-management tools. Participants randomized to the control group received usual care, which varied by site but frequently included a free BP monitor, self-management tools, and linguistically tailored information materials.
The primary outcome was change in systolic BP at 12 months. Secondary outcomes were non-high density lipoprotein cholesterol, hemoglobin A1c, and C-reactive protein (CRP) levels, body mass index, antithrombotic adherence, physical activity level, diet, and smoking status at 12 months. Potential mediators assessed included access to care, health and stroke literacy, self-efficacy, perceptions of care, and BP monitor use.
Among 487 participants included, the mean (SD) age was 57.1 (8.9) years; 317 (65.1%) were men, and 347 participants (71.3%) were Hispanic, 87 participants (18.3%) were Black, and 30 participants (6.3%) were Asian. A total of 246 participants were randomized to usual care, and 241 participants were randomized to the intervention. Mean (SD) systolic BP improved from 143 (17) mm Hg at baseline to 133 (20) mm Hg at 12 months in the intervention group and from 146 (19) mm Hg at baseline to 137 (22) mm Hg at 12 months in the usual care group, with no significant differences in the change between groups. Compared with the control group, participants in the intervention group had greater improvements in self-reported salt intake (difference, 15.4 [95% CI, 4.4 to 26.0]; P = .004) and serum CRP level (difference in log CRP, -0.4 [95% CI, -0.7 to -0.1] mg/dL; P = .003); there were no differences in other secondary outcomes. Although 216 participants (89.6%) in the intervention group received some of the 3 core components, only 35 participants (14.5%) received the intended full dose.
This randomized clinical trial of a complex multilevel, multimodal intervention did not find vascular risk factor improvements beyond that of usual care; however, further studies may consider testing the SUCCEED intervention with modifications to enhance implementation and participant engagement.
ClinicalTrials.gov Identifier: NCT01763203.
很少有中风幸存者能达到推荐的心血管目标,尤其是在种族/族裔少数群体中,如黑人或西班牙裔个体,或社会经济地位不利的人群。
确定基于慢性病护理模式的社区卫生工作者(CHW)、高级实践临床医生(APC;包括执业护士或医师助理)和医生团队干预措施能否在安全网环境(即所有个体均可接受护理,无论其健康保险状况或支付能力如何的医疗保健环境)中改善中风后的危险因素控制。
设计、设置和参与者:这项随机临床试验纳入了从加利福尼亚州洛杉矶县5家为低收入人群服务的医院招募的参与者,作为通过早期联合社区和慢性病护理模式团队消除中风二级预防差异(SUCCEED)临床试验的一部分。纳入标准为年龄40岁及以上;缺血性或出血性中风或短暂性脑缺血发作(TIA)经历不超过90天;收缩压(BP)为130 mmHg或更高,或120至130 mmHg且有高血压病史或正在使用降压药物;以及具备英语或西班牙语能力。排除标准为无法签署知情同意书。在887名接受资格筛查的个体中,542名个体符合条件,487名个体被纳入并随机分组,按中风类型(缺血性或TIA与出血性)、语言(英语与西班牙语)和地点分层,以1:1的方式分为常规护理组和干预组。该研究于2014年2月至2018年9月进行,数据分析于2018年10月至2020年11月进行。
随机分配至干预组的参与者接受多模式协调护理干预,包括假设的核心组成部分(即≥3次APC门诊就诊、≥3次CHW家访以及慢性病自我管理项目工作坊),以及额外的电话随访、方案驱动的危险因素管理、文化和语言定制的教育材料以及自我管理工具。随机分配至对照组的参与者接受常规护理,常规护理因地点而异,但通常包括免费血压监测仪、自我管理工具以及语言定制的信息材料。
主要结局为12个月时收缩压的变化。次要结局为12个月时的非高密度脂蛋白胆固醇、糖化血红蛋白A1c和C反应蛋白(CRP)水平、体重指数、抗血栓治疗依从性、身体活动水平、饮食和吸烟状况。评估的潜在中介因素包括获得护理的机会、健康和中风知识素养、自我效能感以及对护理的认知,以及血压监测仪的使用情况。
在纳入的487名参与者中,平均(标准差)年龄为57.1(8.9)岁;317名(65.1%)为男性,347名参与者(71.3%)为西班牙裔,87名参与者(18.3%)为黑人,30名参与者(6.3%)为亚洲人。共有246名参与者被随机分配至常规护理组,241名参与者被随机分配至干预组。干预组的平均(标准差)收缩压从基线时的143(17)mmHg改善至12个月时的133(20)mmHg,常规护理组从基线时的146(19)mmHg改善至12个月时的137(22)mmHg,两组之间的变化无显著差异。与对照组相比,干预组参与者在自我报告的盐摄入量(差异,15.4 [95% CI,4.4至26.0];P = 0.004)和血清CRP水平(log CRP差异,-0.4 [95% CI,-0.7至-0.1] mg/dL;P = 0.003)方面有更大改善;在其他次要结局方面无差异。尽管干预组中有216名参与者(89.6%)接受了3项核心组成部分中的一些内容,但只有35名参与者(14.5%)接受了预期的全剂量。
这项关于复杂多层次、多模式干预的随机临床试验未发现血管危险因素的改善超过常规护理;然而,进一步的研究可能会考虑对SUCCEED干预措施进行调整后进行测试,以加强实施和提高参与者的参与度。
ClinicalTrials.gov标识符:NCT01763203。